Mapping the Safety Profile of Biologicals: A Disproportionality Analysis Using the WHO Adverse Drug Reaction Database, VigiBase

By Giezen Thijs J.   Mantel-Teeuwisse Aukje K.   Meyboom Ronald H.B.   Straus Sabine M.J.M.   Leufkens Hubert G.M.   Egberts Toine C.G.  

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 865-878

Adis International

Access to resources Recommend Favorite

Suspected Adverse Drug Reactions Reported For Children Worldwide: An Exploratory Study Using VigiBase

By Star Kristina   Norén G. Niklas  

Drug Safety, Vol. 34, Iss. 5, 2011-05 ,pp. : 415-428

Adis International

Access to resources Recommend Favorite

Reporting Patterns Indicative of Adverse Drug Interactions: A Systematic Evaluation in VigiBase

By Strandell Johanna   Caster Ola   Bate Andrew   Norén Niklas   Edwards I. Ralph  

Drug Safety, Vol. 34, Iss. 3, 2011-03 ,pp. : 253-266

Adis International

Access to resources Recommend Favorite

Physicians’ Attitudes and Adverse Drug Reaction Reporting: A Case-Control Study in Portugal

By Herdeiro Maria T.   Figueiras Adolfo  

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 825-833

Adis International

Access to resources Recommend Favorite

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™: Unified List Based on International Collaborative Work

By Suzuki Ayako  

Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. : 503-522

Adis International

Access to resources Recommend Favorite